ATE502049T1 - Peptide und polypeptide mit verbesserter stabilität, die sich für die regeneration des nervensystems eignen - Google Patents

Peptide und polypeptide mit verbesserter stabilität, die sich für die regeneration des nervensystems eignen

Info

Publication number
ATE502049T1
ATE502049T1 AT07872378T AT07872378T ATE502049T1 AT E502049 T1 ATE502049 T1 AT E502049T1 AT 07872378 T AT07872378 T AT 07872378T AT 07872378 T AT07872378 T AT 07872378T AT E502049 T1 ATE502049 T1 AT E502049T1
Authority
AT
Austria
Prior art keywords
ser
trp
seq
peptides
cys
Prior art date
Application number
AT07872378T
Other languages
English (en)
Inventor
Stephane Gobron
Original Assignee
Neuronax
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuronax filed Critical Neuronax
Application granted granted Critical
Publication of ATE502049T1 publication Critical patent/ATE502049T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT07872378T 2006-12-18 2007-12-17 Peptide und polypeptide mit verbesserter stabilität, die sich für die regeneration des nervensystems eignen ATE502049T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0611005A FR2910003B1 (fr) 2006-12-18 2006-12-18 Nouveaux peptides et polypeptides a stabilite amelioree utiles dans la regeneration du systeme nerveux
PCT/FR2007/002089 WO2008090285A2 (fr) 2006-12-18 2007-12-17 Nouveaux peptides et polypeptides à stabilité améliorée utiles dans la régénération du système nerveux

Publications (1)

Publication Number Publication Date
ATE502049T1 true ATE502049T1 (de) 2011-04-15

Family

ID=38229608

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07872378T ATE502049T1 (de) 2006-12-18 2007-12-17 Peptide und polypeptide mit verbesserter stabilität, die sich für die regeneration des nervensystems eignen

Country Status (6)

Country Link
EP (1) EP2118137B1 (de)
AT (1) ATE502049T1 (de)
DE (1) DE602007013289D1 (de)
ES (1) ES2363676T3 (de)
FR (1) FR2910003B1 (de)
WO (1) WO2008090285A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3041644B1 (fr) 2015-09-25 2018-01-05 Neuronax Polypeptides cycliques, leur procede d'obtention et leur application en therapeutique
EP3330284A1 (de) * 2016-12-05 2018-06-06 Neuronax Sa Verwendung von peptidverbindungen zur förderung des überlebens, des wachstums und der zelldifferenzierung
EP3360884A1 (de) 2017-02-10 2018-08-15 Neuronax Verbessertes verfahren zur herstellung eines dodecapeptids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840692A (en) * 1990-02-22 1998-11-24 Allegheny University Of The Health Sciences Peptide fragments and analogs of thrombospondin
FR2766190B1 (fr) * 1997-07-16 2001-11-02 Univ Clermont Auvergne Nouveaux peptides et polypeptides utiles dans la regeneration du systeme nerveux

Also Published As

Publication number Publication date
ES2363676T3 (es) 2011-08-11
EP2118137A2 (de) 2009-11-18
FR2910003B1 (fr) 2012-10-26
WO2008090285A3 (fr) 2008-10-09
WO2008090285A2 (fr) 2008-07-31
FR2910003A1 (fr) 2008-06-20
DE602007013289D1 (de) 2011-04-28
EP2118137B1 (de) 2011-03-16

Similar Documents

Publication Publication Date Title
NZ602351A (en) Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use
NZ600690A (en) Fkbp-l and uses thereof
ATE479761T1 (de) Expression biologisch aktiver polypeptide in wasserlinse
NZ597306A (en) Mesenchymal stem cell differentiation
EP1778842B8 (de) Zusammensetzungen und verfahren zur verwendung von mgd-cdf zur krankheitsbehandlung
RU2002124123A (ru) Модифицированный фактор viii
WO2000037487A8 (de) INHIBITOREN DES INTEGRINS αvβ¿6?
ATE502049T1 (de) Peptide und polypeptide mit verbesserter stabilität, die sich für die regeneration des nervensystems eignen
MX2013011580A (es) Gen insecticida variante axmi115 y metodos para utilizarlo.
FI103796B1 (fi) Proteiini, jolla on kasvinsuojelullisia ominaisuuksia
GB9901499D0 (en) Biological control
DE69837265D1 (de) Polypeptide zur regenerierung des nervensystems
DE60219361D1 (de) Verfahren zur rekombinanten herstellung von plazenta wachstumsfaktor
MXPA01011158A (es) Factor de crecimiento homologo zvegf4.
TW200604207A (en) A superantigen fusion protein and the use thereof
DE60234847D1 (de) N-desoxyribosyltransferase aus lactobacillus, entsprechende nukleinsäuren darauf und ihre verwendungen
NZ591825A (en) Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating fatigue
DE60332213D1 (de) Identifikation von 3-ketosteroid 9-alfa-hydroxylase genen und blockierte mikroorganismen in 3-ketosteroid 9-alfa-hydroxylase aktivität
ATE463510T1 (de) Polypeptide und für diese kodierende gene
MX2025013582A (es) Proteina insecticida y uso de la misma
NZ592583A (en) Use of a plant apyrase enzyme in the modification of endophyte infection
DE59914878D1 (de) Neuer spannungsabhängiger kaliumkanal und seine verwendung zur entwicklung von therapeutika
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
GB2441941A (en) An isolated recombinant vaccinia virus complement control protein (HRVCP) polypeptide
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties